Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
Clinical trial NCT01876784 · COMPLETED
Trial details
- NCT number
- NCT01876784
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-17
- Primary completion
- 2015-08-30
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.